Hostname: page-component-84c44f86f4-nmpfk Total loading time: 0 Render date: 2025-10-14T13:50:24.963Z Has data issue: false hasContentIssue false

Neurocognitive Profiles of Mood Phases in Bipolar Disorder: Is Agitated Depression Related to Mania or Depression?

Published online by Cambridge University Press:  26 August 2025

F. Bardi*
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A. Restaino
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
E. De Chiara
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
C. Calderoni
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
F. Grisoni
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
G. Mandracchia
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A. M. D’Onofrio
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
S. Margoni
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
G. Sani
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy
A. Simonetti
Affiliation:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Agitated Depression (AgD) is a unique subtype of depression marked by impulsivity, higher suicide risk, treatment resistance, and worse clinical outcomes compared to Non-Agitated Depression (Non-AgD). Despite these clinical distinctions, the underlying neuropsychological mechanisms that differentiate AgD from Non-AgD remain poorly defined.

Objectives

This study aims to explore the neurocognitive correlates that differentiate AgD from Non-AgD.

Methods

The study cohort included 722 participants, divided into five groups: AgD, Non-AgD, subjects in a manic state (Mnc), euthymic subjects with bipolar disorder (Eu), and healthy controls (HC). All participants underwent a comprehensive neurocognitive assessment including the Wisconsin Card Sorting Test (WCST), the Interference Component of the Stroop Test (ST), the Semantic Fluency Test (SFT), the Trail-Making Test A and B (TMT-A, TMT-B), and Raven’s Progressive Matrices (RPM). Data were analyzed using one-way ANOVAs and Tukey post-hoc tests to compare cognitive performance across groups.

Results

Non-AgD showed inferior performance compared to AgD on the WCST (non-perseverative errors: p=0.037; perseverative errors: p=0.010; categories identified: p=0.026), ST (p=0.000), TMT-A (p=0.046), and TMT-B (p=0.001). Non-AgD also underperformed Mnc at ST (p=0.002), SFT (p=0.025), TMT-A (p=0.007), TMT-B (p=0.005), and RPM (p=0.012). HC consistently outperformed AgD, Non-AgD, Mnc, and Eu individuals on all neurocognitive tests except for the WCST, where no significant differences were observed between HC, Eu, and AgD. Eu demonstrated superior performance on the WCST (p≤0.001), ST (p=0.000), and TMT (p=0.000) compared to Non-AgD, with no significant differences compared to AgD.

Conclusions

The findings reveal distinct neurocognitive profiles for AgD and Non-AgD. The excitatory mechanisms associated with AgD may contribute to enhance attentional resources and cognitive flexibility but also greater impulse control difficulties. The neuropsychological profile of Eu patients resembles that of AgD, suggesting residual cognitive differences compared to HC. This study enhances our understanding of AgD by highlighting the differences in cognitive profiles of AgD, Non-AgD, Mnc, and Eu, and emphasizing the need of considering neurocognitive factors in the characterization and treatment of AgD.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.